Roweepra

Generic name:levetiracetam
Dosage form: tablet
Drug class:Pyrrolidine anticonvulsants

Medically reviewed by Drugs.com. Last updated on Feb 1, 2022.

Indications and Usage for Roweepra

Partial-Onset Seizures

Roweepra (levetiracetam USP) tablets are indicated for the treatment of partial-onset seizures in patients 1 month of age and older.

Myoclonic Seizures in Patients with Juvenile Myoclonic Epilepsy

Roweepra (levetiracetam USP) tablets are indicated as adjunctive therapy for the treatment of myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy.

Primary Generalized Tonic-Clonic Seizures

Roweepra (levetiracetam USP) tablets are indicated as adjunctive therapy for the treatment of primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy.

Roweepra Dosage and Administration

Important Administration Instructions

Roweepra (levetiracetam USP) is given orally with or without food. The levetiracetam dosing regimen depends on the indication, age group, dosage form (tablets), and renal function.

Prescribe the oral solution for pediatric patients with body weight ≤ 20 kg. Prescribe the oral solution or tablets for pediatric patients with body weight above 20 kg.

When using the oral solution in pediatric patients, dosing is weight-based (mg per kg) using a calibrated measuring device (not a household teaspoon or tablespoon).

Roweepra (levetiracetam USP) tablets should be swallowed whole. Roweepra (levetiracetam USP) tablets should not be chewed or crushed.

Dosing for Partial-Onset Seizures

The recommended dosing for monotherapy and adjunctive therapy is the same; as outlined below.

Adults 16 Years of Age and Older

Initiate treatment with a d...